908 Devices Inc. cash flow statement
In fiscal 2025, 908 Devices Inc.'s operations generated −$23.7m of cash; it spent $955,000 on capital projects, leaving free cash flow of −$24.6m.
Cash flow statement
| Fiscal year | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operations | 4 | −29 | −21 | −25 | −30 | −24 | 1 |
| Depreciation and amortisation | 1 | 1 | 2 | 2 | 5 | 4 | 4 |
| Stock-based pay | 1 | 3 | 7 | 10 | 12 | 10 | 10 |
| Capital spending | 0 | 1 | 2 | 2 | 1 | 1 | 1 |
| Free cash flow | 4 | −30 | −23 | −27 | −31 | −25 | 1 |
| Free cash flow after stock pay | 4 | −32 | −30 | −37 | −43 | −34 | −9 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −6 | −2 | −15 | −6 | −4 | 1 | 1 | 3 |
| Depreciation and amortisation | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| Stock-based pay | 2 | 3 | 2 | 2 | 2 | 3 | 2 | 2 |
| Capital spending | 0 | 0 | 0 | 0 | 1 | −0 | 0 | 0 |
| Free cash flow | −6 | −2 | −15 | −6 | −5 | 1 | 1 | 3 |
| Free cash flow after stock pay | −8 | −5 | −18 | −8 | −7 | −1 | −1 | 1 |
Compare with peers
- Precipio, Inc. cash flow
- Champions Oncology, Inc. cash flow
- Personalis, Inc. cash flow
- Exagen Inc. cash flow
- Burning Rock Biotech Ltd cash flow
Head to head: MASS vs PRPOCSBR vs MASSMASS vs PSNL
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies